HOLLISTER, Calif., May 02, 2023 (GLOBE NEWSWIRE) — Alpha Teknova, Inc. (“Teknova”) TKNO, a leading producer of critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today launched the Company’s first proprietary product line, AAV-Tek™ Solutions, specifically created to address critical pain points…Read More
Teknova Launches Proprietary AAVTek Solutions Gene Therapy Product Line to Accelerate the Development of AAV Therapies Alpha Teknova NASDAQTKNO
